Suvoda is a global clinical trial technology company founded in 2013, specialising in eClinical solutions for complex studies involving life-sustaining therapies. The company's work spans oncology, central nervous system (CNS), and rare disease trials, with operations across more than 115 countries. Since 2024, 34% of FDA-approved trials in its portfolio have used its platform.
The company's core offering is its Unified Platform, which integrates RTSM (IRT), eCOA, eConsent, patient payments, travel services, scheduling, and site payments into a single system. The platform uses a patented architecture built on no-code and low-code approaches, aimed at streamlining the clinical trial journey for sponsors, sites, and patients.
Suvoda's technical domains cover a broad range of eClinical technologies. Its platform is designed to handle the operational complexity that characterises trials for therapies where patient outcomes depend on precise coordination of supply, data collection, and regulatory compliance.
